Norinchukin Bank, The Regeneron Pharmaceuticals, Inc. Transaction History

Norinchukin Bank, The

  • $3.32 Billion
  • Q1 2024

A detailed history of Norinchukin Bank, The transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Norinchukin Bank, The holds 4,571 shares of REGN stock, worth $4.73 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,571
Previous 4,707 2.89%
Holding current value
$4.73 Million
Previous $4.13 Million 6.41%
% of portfolio
0.13%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $122,765 - $135,095
-136 Reduced 2.89%
4,571 $4.4 Million
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $517,820 - $588,975
-668 Reduced 12.43%
4,707 $4.13 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $3.72 Million - $4.54 Million
5,375 New
5,375 $4.42 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $1.8 Million - $2.13 Million
2,568 Added 30.51%
10,985 $7.89 Million
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $150,388 - $182,760
221 Added 2.7%
8,417 $6.92 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $1.31 Million - $1.42 Million
-1,858 Reduced 18.48%
8,196 $5.91 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $560,768 - $707,660
977 Added 10.76%
10,054 $6.93 Million
Q2 2022

Aug 10, 2022
SELL
$548.35 - $738.84 $1.07 Million - $1.45 Million
-1,959 Reduced 17.75%
9,077 $5.37 Million
Q1 2022

May 12, 2022
BUY
$595.12 - $698.43 $633,802 - $743,827
1,065 Added 10.68%
11,036 $7.71 Million
Q4 2021

Feb 10, 2022
SELL
$543.48 - $670.97 $288,587 - $356,285
-531 Reduced 5.06%
9,971 $6.3 Million
Q3 2021

Nov 09, 2021
BUY
$574.03 - $680.96 $353,602 - $419,471
616 Added 6.23%
10,502 $6.36 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $61,464 - $72,610
130 Added 1.33%
9,886 $5.52 Million
Q1 2021

May 12, 2021
BUY
$446.73 - $548.2 $207,729 - $254,913
465 Added 5.0%
9,756 $4.62 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $5,261 - $6,687
-11 Reduced 0.12%
9,291 $4.49 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $331,752 - $400,849
609 Added 7.01%
9,302 $5.21 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $810,524 - $1.06 Million
1,643 Added 23.3%
8,693 $5.42 Million
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $1.3 Million - $1.91 Million
-3,853 Reduced 35.34%
7,050 $3.44 Million
Q4 2019

Feb 12, 2020
SELL
$274.13 - $376.51 $239,863 - $329,446
-875 Reduced 7.43%
10,903 $4.09 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $114,306 - $133,087
418 Added 3.68%
11,778 $3.27 Million
Q2 2019

Aug 09, 2019
SELL
$299.6 - $414.82 $1.14 Million - $1.59 Million
-3,821 Reduced 25.17%
11,360 $3.56 Million
Q1 2019

May 10, 2019
BUY
$372.08 - $439.57 $260,828 - $308,138
701 Added 4.84%
15,181 $6.23 Million
Q4 2018

Feb 08, 2019
BUY
$335.82 - $403.04 $1.52 Million - $1.82 Million
4,514 Added 45.29%
14,480 $5.41 Million
Q3 2018

Nov 08, 2018
BUY
$351.14 - $408.51 $422,070 - $491,029
1,202 Added 13.72%
9,966 $4.03 Million
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $480,404 - $582,343
1,688 Added 23.86%
8,764 $3.02 Million
Q1 2018

May 10, 2018
BUY
$315.82 - $393.78 $289,291 - $360,702
916 Added 14.87%
7,076 $2.44 Million
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $158,155 - $207,247
441 Added 7.71%
6,160 $2.32 Million
Q3 2017

Nov 08, 2017
BUY
$431.38 - $504.0 $2.47 Million - $2.88 Million
5,719
5,719 $2.56 Million

Others Institutions Holding REGN

# of Institutions
1,427
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $111B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email